<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35421079</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>15</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2020-2021.</ArticleTitle><Pagination><StartPage>538</StartPage><EndPage>544</EndPage><MedlinePgn>538-544</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7115a2</ELocationID><Abstract><AbstractText>Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of reported poliomyelitis cases worldwide has declined by approximately 99.99%. By the end of 2021, wild poliovirus (WPV) remained endemic in only two countries (Pakistan and Afghanistan). However, a WPV type 1 (WPV1) case with paralysis onset in 2021, was reported by Malawi a year after the World Health Organization (WHO) African Region (AFR) was certified as WPV-free and circulating vaccine-derived poliovirus (cVDPV) cases were reported from 31 countries during 2020-2021 (1,2). cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity and cause paralysis. The primary means of detecting poliovirus transmission is through surveillance for acute flaccid paralysis (AFP) among persons aged &lt;15 years, with confirmation through stool specimen testing by WHO-accredited laboratories, supplemented by systematic sampling of sewage and testing for the presence of poliovirus (environmental surveillance). The COVID-19 pandemic caused disruptions in polio vaccination and surveillance activities across WHO regions in 2020; during January-September 2020, the number of reported cases of AFP declined and the interval between stool collection and receipt by laboratories increased compared with the same period in 2019 (3). This report summarizes surveillance performance indicators for 2020 and 2021 in 43 priority countries* and updates previous reports (4). In 2021, a total of 32 (74%) priority countries<sup>&#x2020;</sup> met two key surveillance performance indicator targets nationally, an improvement from 2020 when only 23 (53%) met both targets; however, substantial national and subnational gaps persist. High-performing poliovirus surveillance is critical to tracking poliovirus transmission. Frequent monitoring of surveillance indicators could help identify gaps, guide improvements, and enhance the overall sensitivity and timelines of poliovirus detection to successfully achieve polio eradication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>Amanda L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Diop</LastName><ForeName>Ousmane M</ForeName><Initials>OM</Initials></Author><Author ValidYN="Y"><LastName>Jorba</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Gardner</LastName><ForeName>Tracie</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Snider</LastName><ForeName>Cynthia J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Jamal</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35421079</ArticleId><ArticleId IdType="pmc">PMC9020859</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7115a2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bigouette JP, Wilkinson AL, Tallis G, Burns CC, Wassilak SGF, Vertefeuille JF. Progress toward polio eradication&#x2014;worldwide, January 2019&#x2013;June 2021. MMWR Morb Mortal Wkly Rep 2021;70:1129&#x2013;35. 10.15585/mmwr.mm7034a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7034a1</ArticleId><ArticleId IdType="pmc">PMC8389387</ArticleId><ArticleId IdType="pubmed">34437527</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman MM, Jorba J, Henderson E, et al. Update on vaccine-derived poliovirus outbreaks&#x2014;worldwide, January 2020&#x2013;June 2021. MMWR Morb Mortal Wkly Rep 2021;70:1691&#x2013;9. 10.15585/mmwr.mm7049a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7049a1</ArticleId><ArticleId IdType="pmc">PMC8659190</ArticleId><ArticleId IdType="pubmed">34882653</ArticleId></ArticleIdList></Reference><Reference><Citation>Zomahoun DJ, Burman AL, Snider CJ, et al. Impact of COVID-19 pandemic on global poliovirus surveillance. MMWR Morb Mortal Wkly Rep 2021;69:1648&#x2013;52. 10.15585/mmwr.mm695152a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm695152a4</ArticleId><ArticleId IdType="pmc">PMC9191906</ArticleId><ArticleId IdType="pubmed">33382673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuma JN, Wilkinson AL, Diop OM, et al. Surveillance to track progress toward polio eradication&#x2014;worldwide, 2019&#x2013;2020. MMWR Morb Mortal Wkly Rep 2021;70:667&#x2013;73. 10.15585/mmwr.mm7018a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7018a2</ArticleId><ArticleId IdType="pmc">PMC9368747</ArticleId><ArticleId IdType="pubmed">33956779</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Wild poliovirus type 1 (WPV1)&#x2014;Malawi. Geneva, Switzerland: World Health Organization; 2022. https://www.who.int/emergencies/disease-outbreak-news/item/wild-poliovirus-type-1-(WPV1)-malawi</Citation></Reference><Reference><Citation>Asghar H, Diop OM, Weldegebriel G, et al. Environmental surveillance for polioviruses in the Global Polio Eradication Initiative. J Infect Dis 2014;210(Suppl 1):S294&#x2013;303. 10.1093/infdis/jiu384</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu384</ArticleId><ArticleId IdType="pmc">PMC10578309</ArticleId><ArticleId IdType="pubmed">25316848</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadigh KS, Akbar IE, Wadood MZ, et al. Progress toward poliomyelitis eradication&#x2014;Afghanistan, January 2020&#x2013;November 2021. MMWR Morb Mortal Wkly Rep 2022;71:85&#x2013;9. 10.15585/mmwr.mm7103a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7103a3</ArticleId><ArticleId IdType="pmc">PMC8774155</ArticleId><ArticleId IdType="pubmed">35051135</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C, Baig S, Khan Z, et al. Progress toward poliomyelitis eradication&#x2014;Pakistan, January 2020&#x2013;July 2021. MMWR Morb Mortal Wkly Rep 2021;70:1359&#x2013;64. 10.15585/mmwr.mm7039a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7039a1</ArticleId><ArticleId IdType="pmc">PMC8486386</ArticleId><ArticleId IdType="pubmed">34591827</ArticleId></ArticleIdList></Reference><Reference><Citation>Diop OM, Kew OM, de Gourville EM, Pallansch MA. The Global Polio Laboratory Network as a platform for the viral vaccine-preventable and emerging diseases laboratory networks. J Infect Dis 2017;216(suppl_1):S299&#x2013;307. 10.1093/infdis/jix092</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix092</ArticleId><ArticleId IdType="pmc">PMC5853949</ArticleId><ArticleId IdType="pubmed">28838192</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Global Polio Surveillance Action Plan (GPSAP). 2022&#x2013;2024 [prepublication version]. Geneva, Switzerland: World Health Organization; 2022. https://polioeradication.org/wp-content/uploads/2022/02/Global-Polio-Surveillance-Action-Plan-2022-2024.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>